Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Amylyx Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/24/2023 |
4/A
| FRATES JAMES M (CFO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 30,796 shares
@ $31.8593, valued at
$981.1k
Sold 1,704 shares
@ $32.4649, valued at
$55.3k
Granted 21,667 shares
@ $0
Granted 97,500 options to buy
@ $32.08, valued at
$3.1M
Exercised 32,500 options to buy
@ $6.88, valued at
$223.6k
|
|
| 03/24/2023 |
4/A
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 52,211 shares
@ $31.8485, valued at
$1.7M
Sold 2,416 shares
@ $32.4331, valued at
$78.4k
Granted 9,167 shares
@ $0
Granted 41,250 options to buy
@ $32.08, valued at
$1.3M
Exercised 2,789 options to buy
@ $0.33, valued at
$920.4
Exercised 30,041 options to buy
@ $0.37, valued at
$11.1k
Exercised 16,748 options to buy
@ $6.88, valued at
$115.2k
|
|
| 03/17/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|